TP53 and gastric carcinoma: EBV-miR-BART5-3p, EBV-miR-BART4-5p, and EBV-miR-BART20-5p promote the growth and inhibit the apoptosis of gastric carcinoma cells by directly targeting the tumor suppressor gene TP53 3'-UTR, BID 3'-UTR and the 3'-UTR of BAD, respectively [14, 21, 35].